CytoImmune Therapeutics
www.cytoimmune.comCytoImmune Therapeutics, LLC develops novel, coordinated immunotherapy solutions for patients. Our CoalesceNT™ platform harnesses the power of bispecific antibody (biAb) and chimeric antigen receptor (CAR) technology to coordinate an immune response with both natural killer (NK) and T cells. This combination of NK- and T-cell therapy expedites time-to-treatment and delivers a dynamic immune response that reflects natural immunity.
Read more
CytoImmune Therapeutics, LLC develops novel, coordinated immunotherapy solutions for patients. Our CoalesceNT™ platform harnesses the power of bispecific antibody (biAb) and chimeric antigen receptor (CAR) technology to coordinate an immune response with both natural killer (NK) and T cells. This combination of NK- and T-cell therapy expedites time-to-treatment and delivers a dynamic immune response that reflects natural immunity.
Read more
Country
State
California
City (Headquarters)
Monrovia
Industry
Employees
1-10
Founded
2019
Social
Employees statistics
View all employeesPotential Decision Makers
Vice President Regulatory Affairs
Email ****** @****.comPhone (***) ****-****Chief Operations Officer
Email ****** @****.comPhone (***) ****-****President
Email ****** @****.comPhone (***) ****-****Director of Research
Email ****** @****.comPhone (***) ****-****
Technologies
(10)
We'll help you understand if Lusha can solve your business needs.
